Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 6/20 | 1.00 |
| ▸ | SLC22A1 | O15245 | 3/20 | 0.81 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.77 |
| ▸ | TP53 | P04637 | 1/20 | 0.77 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.77 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.77 |
| ▸ | TSHR | P16473 | 1/20 | 0.77 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.77 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.77 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.77 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.77 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.75 |
| ▸ | HTT | P42858 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17418374 | 1.00 | DNM1 (1.00) | DNM1SLC22A1ALDH1A1TP53CYP3A4 | |
| SCHEMBL331847 | 1.00 | DNM1 (1.00) | DNM1SLC22A1ALDH1A1TP53CYP3A4 | |
| SCHEMBL5304363 | 1.00 | DNM1 (1.00) | DNM1SLC22A1ALDH1A1TP53CYP3A4 | |
| SCHEMBL1010481 | 1.00 | DNM1 (1.00) | DNM1SLC22A1ALDH1A1TP53CYP3A4 | |
| SCHEMBL1842974 | 1.00 | DNM1 (1.00) | DNM1SLC22A1ALDH1A1TP53CYP3A4 | |
| SCHEMBL640740 | 1.00 | DNM1 (1.00) | DNM1SLC22A1ALDH1A1TP53CYP3A4 | |
| SCHEMBL923926 | 1.00 | DNM1 (1.00) | DNM1SLC22A1ALDH1A1TP53CYP3A4 | |
| SCHEMBL332106 | 1.00 | DNM1 (1.00) | DNM1SLC22A1ALDH1A1TP53CYP3A4 | |
| SCHEMBL5300928 | 1.00 | DNM1 (1.00) | DNM1SLC22A1ALDH1A1TP53CYP3A4 | |
| SCHEMBL5287730 | 1.00 | DNM1 (1.00) | DNM1SLC22A1ALDH1A1TP53CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 219 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1960345-B1 | ALKYLATION OF N' -PHENYL-N-ALKYLPHENYLENEDIAMINES IN IONIC LIQUID, AND N' -PHENYL-N-ALKYL(ALKYLPHENYLENE) DIAMINES PRODUCED THEREBY | CHEMTURA CORP (US) | 2014-11-19 | — | — | EP | claimed |
| EP-1963253-B1 | RING ALKYLATION OF ANILINE OR AN ANILINE DERIVATIVE USING IONIC LIQUID CATALYSTS | CHEMTURA CORP (US) | 2011-01-05 | — | — | EP | claimed |
| EP-1960344-B1 | ALKYLATION OF A DIPHENYLAMINE COMPOUND IN IONIC LIQUID | CHEMTURA CORP (US) | 2010-09-29 | — | — | EP | claimed |
| EP-1439146-B1 | Control process of expansion properties of thermally expansible graphite-sulfuric acid particles and their use. | HILTI AG (LI) | 2009-10-14 | — | — | EP | claimed |
| US-7563929-B2 | Alkylation of N′-phenyl-N-alkylphenylenediamines in ionic liquid and N′-phenyl-N-alkyl(alkylphenylene) diamines produced thereby | CHEMTURA CORPORATION (US) | 2009-07-21 | — | — | US | claimed |
| US-20080234517-A1 | ALKYLATION OF N'-PHENYL-N-ALKYLPHENYLENEDIAMINES IN IONIC LIQUID AND N'-PHENYL-N-ALKYL(ALKYLPHENYLENE) DIAMINES PRODUCED THEREBY | CHEMTURA CORPORATION (US) | 2008-09-25 | — | — | US | claimed |
| EP-1963253-A2 | RING ALKYLATION OF ANILINE OR AN ANILINE DERIVATIVE USING IONIC LIQUID CATALYSTS | CHEMTURA CORPORATION (US) | 2008-09-03 | — | — | EP | claimed |
| EP-1960345-A1 | ALKYLATION OF N' -PHENYL-N-ALKYLPHENYLENEDIAMINES IN IONIC LIQUID, N' -PHENYL-N-ALKYL(ALKYLPHENYLENE) DIAMINES PRODUCED THEREBY, AND LUBRICANT COMPOSITIONS CONTAINING SAME | CHEMTURA CORPORATION (US) | 2008-08-27 | — | — | EP | claimed |
| EP-1960344-A1 | ALKYLATION OF A DIPHENYLAMINE COMPOUND IN IONIC LIQUID | CHEMTURA CORPORATION (US) | 2008-08-27 | — | — | EP | claimed |
| US-7378554-B2 | Ring alkylation of aniline or an aniline derivative using ionic liquid catalysts | CHEMTURA CORPORATION (US) | 2008-05-27 | — | — | US | claimed |
| EP-1846152-A1 | STABILIZED CRYSTALLIZED CATANIONIC NANODISCS, METHOD FOR PREPARING SAME AND USES THEREOF | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2007-10-24 | — | — | EP | claimed |
| WO-2007070264-A1 | ALKYLATION OF A DIPHENYLAMINE COMPOUND IN IONIC LIQUID | CHEMTURA CORPORATION (US) | 2007-06-21 | — | — | WO | claimed |
| WO-2007070282-A1 | ALKYLATION OF N' -PHENYL-N-ALKYLPHENYLENEDIAMINES IN IONIC LIQUID, N' -PHENYL-N-ALKYL(ALKYLPHENYLENE) DIAMINES PRODUCED THEREBY, AND LUBRICANT COMPOSITIONS CONTAINING SAME | CHEMTURA CORPORATION (US) | 2007-06-21 | — | — | WO | claimed |
| WO-2007070263-A2 | RING ALKYLATION OF ANILINE OR AN ANILINE DERIVATIVE USING IONIC LIQUID CATALYSTS | CHEMTURA CORPORATION (US) | 2007-06-21 | — | — | WO | claimed |
| US-20070135656-A1 | Ring alkylation of aniline or an aniline derivative using ionic liquid catalysts | LANXESS SOLUTIONS US INC. | 2007-06-14 | — | — | US | claimed |
| US-20070135657-A1 | Alkylation of N'-phenyl-N-alkylphenylenediamines in ionic liquid, N'-phenyl-N-alkyl (alkylphenylene) diamines produced thereby, and lubricant compositions containing same | LANXESS SOLUTIONS US INC. | 2007-06-14 | — | — | US | claimed |
| US-7145038-B1 | Alkylation of a diphenylamine compound in ionic liquid | CHEMTURA CORPORATION (US) | 2006-12-05 | — | — | US | claimed |
| EP-1718406-A1 | POLYMER-STABILISED, CRYSTALLISED, CATANIONIC MEMBRANES, PREPARATION METHOD THEREOF AND APPLICATIONS OF SAME | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2006-11-08 | — | — | EP | claimed |
| WO-2006070095-A1 | STABILIZED CRYSTALLIZED CATANIONIC NANODISCS, METHOD FOR PREPARING SAME AND USES THEREOF | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2006-07-06 | — | — | WO | claimed |
| WO-2005089927-A1 | POLYMER-STABILISED, CRYSTALLISED, CATANIONIC MEMBRANES, PREPARATION METHOD THEREOF AND APPLICATIONS OF SAME | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2005-09-29 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080234517-A1 | ALKYLATION OF N'-PHENYL-N-ALKYLPHENYLENEDIAMINES IN IONIC LIQUID AND N'-PHENYL-N-ALKYL(ALKYLPHENYLENE) DIAMINES PRODUCED THEREBY | PNMT, PNN, INMT | DNM1 3969/4885SLC22A1 1209/4885ALDH1A1 1010/4885 |
| US-20070135657-A1 | Alkylation of N'-phenyl-N-alkylphenylenediamines in ionic liquid, N'-phenyl-N-alkyl (alkylphenylene) diamines produced thereby, and lubricant compositions containing same | NAPEPLD, PNN, ACR | DNM1 2800/4885SLC22A1 2057/4885ALDH1A1 619/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.